Canid, a NYC-based, developer of a healthcare dashboard and process tool intended to simplify vaccination record management. The company’s tool offers administrative consulting, secures vaccine margins, automates your vaccine workflow, and oversees vaccine inventory, enabling state officials and pediatric practitioners to focus on their day-to-day practice.
Canid was funded $10 million led by Telescope Partners with participation from FJ Labs, Brooklyn Bridge Ventures, SeedtoB and other strategic angel investors. The new funding aims to expand Canid’s innovative vaccine management platform across ten additional U.S. states and enhance tools for managing pediatric vaccine patient populations.
Founded in 2020 by CEO Pedro Sanchez de Lozada, Canid offers an end-to-end solution designed to alleviate the administrative burdens associated with vaccine management in pediatric practices. The platform automates various aspects of vaccine operations, including purchasing, billing, inventory tracking, and patient outreach, allowing healthcare providers to focus more on patient care.
Sanchez de Lozada commented the vaccinations have been taken for granted for decades. They’re the #1 most valuable public health tool we have as a society, and yet they’re always the last priority for our healthcare system. Their goal at Canid is to change that. By eliminating the burden out of giving and receiving vaccines, they hope to make it exciting again to take part.
Canid’s platform addresses critical challenges faced by pediatricians, such as the financial strain of vaccine procurement and the complexity of insurance reimbursements. By purchasing vaccines on behalf of practices and managing billing processes, Canid ensures that providers receive full compensation for their services. The system also automates inventory management, reducing the risk of stockouts or overstocking, and facilitates the organization of mass vaccination clinics through an integrated scheduling feature.
The recent funding will support Canid’s expansion into new markets, particularly in the Southwest and Midwest regions of the United States. The company plans to leverage this growth to improve vaccination rates and public health outcomes by providing practices with tools to identify under-vaccinated children and streamline patient outreach campaigns.
As Canid continues to grow, its mission remains focused on supporting independent pediatric practices by reducing administrative burdens and enhancing the efficiency of vaccine delivery. By doing so, the company aims to ensure that children receive timely vaccinations, ultimately contributing to better public health outcomes.
By: K. Tagura
Who we are: Funded.com is a platform that is A+ BBB accredited over 10+ years. Access our network of Angel Investors, Venture Capital or Lenders. Let us professionally write your Business Plan.
Rss Feed
